Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bob smith who wrote (14075)	2/2/1998 5:35:00 PM
From: JOEBT1	Read Replies (2) \| Respond to of 32384

"and LGND is still down 40% from its high"--I know how you feel but don't get discouraged. There has been some steady selling by some institutions or technical momentum players which should abate soon. Some good announcements should be forthcoming soon:4th qt. report; LLY drug or money/royalty; trial results etc. When the market realizes the potential for blockbuster drugs LGND will explode to the up side. For example Targetrin / panretin is as good as tamoxifen for breast cancer and the combination (tamoxifen and Targretrin or Panretin) is syngergistic and and should be more effective than either alone. FWIW I'm looking to do more buying.